Cargando…
Management of Brain Metastases from Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Cancer
SIMPLE SUMMARY: Treatment options for patients with Human Epidermal growth factor Receptor 2 positive (HER2+) metastatic breast cancer are rapidly changing, especially for patients with brain metastasis. Historically, treatment options for brain metastasis were focused on local therapies, radiation...
Autores principales: | McGranahan, Tresa M., Bonm, Alipi V., Specht, Jennifer M., Venur, Vyshak, Lo, Simon S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601150/ https://www.ncbi.nlm.nih.gov/pubmed/36291922 http://dx.doi.org/10.3390/cancers14205136 |
Ejemplares similares
-
A Neuro-oncologist’s Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer
por: McGranahan, Tresa, et al.
Publicado: (2017) -
Targeted Therapies for Brain Metastases from Breast Cancer
por: Venur, Vyshak Alva, et al.
Publicado: (2016) -
History and current state of immunotherapy in glioma and brain metastasis
por: McGranahan, Tresa, et al.
Publicado: (2017) -
Current State of Immunotherapy for Treatment of Glioblastoma
por: McGranahan, Tresa, et al.
Publicado: (2019) -
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
por: Feilchenfeldt, J, et al.
Publicado: (2015)